Jenna Davidner
Stock Analyst at Barclays
(0.70)
# 4,135
Out of 5,022 analysts
27
Total ratings
42.1%
Success rate
-7.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jenna Davidner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals | Initiated: Buy | $100 → $110 | $77.64 | +41.68% | 7 | Sep 17, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $9 → $12 | $7.78 | +54.24% | 4 | Aug 20, 2026 | |
| COLL Collegium Pharmaceutical | Reiterated: Buy | $56 → $48 | $22.19 | +116.31% | 7 | Aug 18, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Hold | $25 | $24.91 | +0.36% | 5 | Aug 17, 2026 | |
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | $18 → $14 | $7.69 | +82.05% | 4 | Aug 17, 2026 |
Tarsus Pharmaceuticals
Sep 17, 2026
Initiated: Buy
Price Target: $100 → $110
Current: $77.64
Upside: +41.68%
Xeris Biopharma Holdings
Aug 20, 2026
Reiterated: Buy
Price Target: $9 → $12
Current: $7.78
Upside: +54.24%
Collegium Pharmaceutical
Aug 18, 2026
Reiterated: Buy
Price Target: $56 → $48
Current: $22.19
Upside: +116.31%
Pacira BioSciences
Aug 17, 2026
Reiterated: Hold
Price Target: $25
Current: $24.91
Upside: +0.36%
Phathom Pharmaceuticals
Aug 17, 2026
Reiterated: Buy
Price Target: $18 → $14
Current: $7.69
Upside: +82.05%